Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

pms-Clonazepam (2016-09-06)

Starting date:
September 6, 2016
Posting date:
September 20, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-60302

Affected Product

pms-Clonazepam

Reason

This lot of Clonazepam 1 mg may contain tablets of Terazosin-HCl 5 mg.

Depth of distribution

Canada: wholesalers, pharmacies

Affected products

pms-Clonazepam

DIN, NPN, DIN-HIM
DIN 02048728
Dosage form

Tablet

Strength

1 mg

Lot or serial number

499048

Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA